NANO Nuclear Energy vs. NuScale Power: Which Stock Is a Better Buy in 2026?

The race for carbon-free energy is heating up as companies compete to revolutionize the nuclear sector. Investors are now deciding between NANO Nuclear Energy (NASDAQ:NNE) and NuScale Power (NYSE:SMR) for growth.

NANO Nuclear focuses on portable microreactors designed for remote locations and space, while NuScale develops small modular reactors (SMRs) for large-scale utility grids. Both companies represent the next generation of nuclear power, but they differ significantly in technology scale, commercial progress, and financial stability. This comparison explores which one fits your risk tolerance better.

The case for NANO Nuclear Energy

NANO Nuclear designs advanced microreactors intended for rapid deployment in remote regions or space, specifically targeting niche markets where traditional energy infrastructure is currently unavailable. Its flagship KRONOS technology aims to provide mobile power for military use or industrial sites, and the company has already provided consulting services for projects like power plant site assessments. Customer concentration like this adds a layer of risk to the business since revenue depends on a very limited number of early developmental partnerships.

In its latest annual report, filed for FY 2025, NANO Nuclear reported revenue of nearly $0.0 while remaining in its pre-commercial development phase. This resulted in an ongoing net loss of approximately $40.1 million for the period, which represents a significant increase from the negative $10.2 million reported in the previous year. These rising figures reflect the heavy costs of engineering, research, and complex regulatory filings required to bring its novel microreactor technology to the global market.

As of its September 2025 balance sheet, the current ratio was nearly 53.5x and the debt-to-equity ratio was approximately 0.0x, indicating that total debt is minimal relative to shareholder equity. This high current ratio suggests the company has a substantial liquidity runway to continue its research and development without immediate financial distress. Free cash flow was close to negative $37.1 million, representing cash from operations minus capital expenditures as the company invests in its core reactor designs.

The case for NuScale Power

NuScale Power develops small modular reactors that provide carbon-free energy for the in the industrial stocks sector and large utility grids worldwide. Its 12-module plants are specifically designed to power high-demand facilities like data centers while its strategic partnership with ENTRA1 facilitates international distribution and commercialization efforts. The company serves diverse global markets including electrical generation, district heating, and desalination in an effort to establish the first commercial small-scale nuclear plants.

In its latest annual report, filed for FY 2025, revenue reached nearly $31.5 million, representing a decrease of approximately 15% compared to the prior year. This decline contributed to a net loss of close to $355.8 million and a negative net margin of approximately 1,130.3% for the fiscal year. These substantial losses are primarily due to the heavy capital requirements, engineering costs, and the long regulatory timelines involved in bringing new nuclear technology to a commercial scale.

As of its December 2025 balance sheet, the company maintained a current ratio of roughly 4.3x and a debt-to-equity ratio of approximately 0.0x. A current ratio assesses the ability to meet short-term obligations using current assets, while debt-to-equity shows the balance between borrowed funds and shareholder equity. Free cash flow was close to negative $460.1 million, representing cash generated from operations minus capital expenditures as the company builds out its manufacturing and deployment capabilities.

Risk profile comparison

NANO Nuclear faces significant ongoing operating losses and requires substantial additional capital to fund development through the early 2030s. There are legal risks from securities law class action lawsuits, while the unproven KRONOS technology carries high execution and regulatory risks. Potential conflicts of interest exist because executive officers hold roles at other entities.

NuScale deals with securities fraud class action lawsuits while remaining heavily dependent on the exclusive strategic partnership with ENTRA1. The company also faces intense competition from modular reactor technologies in Russia and China. Additionally, it must navigate negotiations with the Tennessee Valley Authority (NYSE:TVC) for future deployments.

Which stock would I buy in 2026?

I'd go with NuScale, though this is a pretty speculative pick. Both companies are pre-revenue on nuclear power, both are diluting shareholders to stay funded, and both are years away from commercial scale. Anyone buying either stock should understand they are making a long-term bet on unproven technology.

That said, NuScale has two key advantages right now. It holds the only small modular reactor design with full U.S. regulatory certification, which puts it well ahead of NANO Nuclear on the path to commercial deployment. And despite collapsing revenue, NuScale raised nearly a billion dollars in fresh capital in the first half of 2026, building a cash runway that gives it real time to execute.

NANO Nuclear has an interesting portable micro-reactor concept and decent liquidity, but its NRC construction permit is still in its earliest stages. So it is further behind on the regulatory timeline than NuScale despite being positioned as the more innovative play. Between the two long shots, NuScale's regulatory lead and larger cash cushion make it the slightly more grounded starting point for me.

Sara Appino has no position in any of the stocks mentioned. The Motley Fool recommends NuScale Power. The Motley Fool has a disclosure policy.